Tim Lancaster of Indigo BioAutomation and Mark Perkins of The Binding Site join us to share how they’re bringing artificial intelligence and mass spectrometry together to make significant improvements in the world of multiple myeloma.
Mark’s team saw a massive opportunity to improve multiple myeloma diagnostics, but they knew they needed a software partner. Tim’s team at Indigo Bioautomation proved to be the perfect fit. Mark and Tim share about their powerful partnership and their journey from turning an idea to a tool that will change patients’ lives.
You can find more information about this podcast at sep.com/podcast and subscribe wherever you get your podcasts. Thanks for listening!
